We are live on ! Find out more
MOLN

Molecular Partners
MOLN

5 hedge funds and large institutions have $4.2M invested in Molecular Partners in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% less ownership

Funds ownership: 2.35% → 2.31% (-0.03%)

32% less capital invested

Capital invested by funds: $6.18M → $4.2M (-$1.98M)

38% less funds holding

Funds holding: 8 → 5 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$10.9K
2
Morgan Stanley
Morgan Stanley
New York
+$813

Top Sellers

Rank Fund Capital Flow
1
OMC
Old Mission Capital
Illinois
-$74.9K
2
TCM
Tang Capital Management
California
-$18.1K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$114

MOLN Hedge Fund Activity: Q3 2024 in Review

5 of the 6,977 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q3 2024, worth a combined $4.2M — down 32% from $6.18M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of MOLN and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, adding an estimated $10.9K. The largest seller was Old Mission Capital, exiting entirely with an estimated $74.9K sold.

  • 5 institutional investors held Molecular Partners (MOLN) as of Q3 2024, down from 8 in Q2 2024.
  • Funds reported $4.2M of Molecular Partners stock for Q3 2024, down 32% quarter-over-quarter.
  • 0 funds opened new Molecular Partners positions in Q3 2024 and 3 closed out, a net change of -3 holders.
  • The largest Molecular Partners buyer in Q3 2024 was UBS Group, an estimated $10.9K added.
  • The largest Molecular Partners seller in Q3 2024 was Old Mission Capital, an estimated $74.9K sold.

Based on aggregated 13F filings for Q3 2024.